CURRICULUM VITAE

Name:                                Tsunenori Kondo

Sex:                                   Male

Birth Date:                        January 8, 1966

Birth Place:                       Ibaraki, Japan

Citizenship:                       Japan

Present address:                7-6-16-101 Hikarigaoka

                                          Nerima-ku, Tokyo 179-0072 Japan

Business address:                           Dept. of Urology

                                          Tokyo Women’s Medical University

                                          8-1 Kawada-cho

                                          Shinjuku-ku, Tokyo 162-8666 Japan

Education:

• D. (Dr. of Medical Science), Tokyo Women’s Medical University

(Thesis: Induction of chemokine during allograft rejection)

              1990      M.D.,    cum laude, Hokkaido University School of Medicine

• Graduated from High School

Professional Training and Employment:

Jan. 2017 – present         Professor and Chairman, Department of Urology, Tokyo Women’s Medical University Medical Center East, Tokyo

Dec. 2013 – Dec. 2016   Associate Professor, Department of Urology, Tokyo Women’s Medical University, Tokyo

Mar.2006 – Nov.2013     Assistant Professor, Department of Urology, Tokyo Women’s Medical University, Tokyo

Jan.2004 – Fer.2006        Instructor, Department of Urology, Tokyo Women’s Medical University, Tokyo

Jan.2002 – Dec.2003      Head, Department of Urology, Toda Chuo General Hospital, Saitama, Japan

Jul.1996 – Dec.2001       Instructor, Department of Urology, Tokyo Women’s Medical University, Tokyo

Feb.1994 – Jun.1996      Research Fellow, Department of Urology, Cleveland Clinic Foundation, Cleveland, Ohio

May.1990 – Jan.1994      Resident in Department of Urology, Tokyo Women’s Medical University

• Passed the Examination of National Board

Societies:

• The Japanese Urological Association
• European Association of Urology
• American Urological Association
• Japanese Cancer Association
• Japanese Society of Clinical Oncology
• Japanese Association of Transplantation
• Japanese Society for Dialysis Therapy
• Japanese Society of Endourology and ESWL
• Japan Association of Endocrine Surgeons
• Japanese Society for Clinical Renal Transplantation
• Japanese Society of Renal Transplantation, Vascular Surgery
• Japanese Society of Renal Cancer
• Japanese Society of Nephrology

Professional activities;

• Councilor: Japanese Urological Association, 2016-present
• Board member: Japanese Society of Renal Cancer, 2009-present
• Board member; International Cancer Conference Journal, 2011-present
• Board member; Japanese Journal of Clinical Oncology, 2012-present
• Representative board member: Caesur Seminar, 2010-present
• Board member: General Rule for Clinical and Pathological Studies on Renal Pelvic, 2011- present
• Board member: Guideline committed for urothelial carcinoma of the upper urinary tract of Japanese Urological Association, 2013- present
• Board member: Guideline committed for Renal Cell Carcinoma of Japanese Urological Association, 2015- present
• Board member: Guideline committed for Laparoscopic Urologic Surgery of Japanese Urological Association, 2017- present
• Board member: Guideline committed for urothelial carcinoma of the upper urinary tract of International Committee of Urological Disease, Ureteral and Bladder cancer, 2010-present

Award

• Recipient of Best Poster in 2014 WCE annual meeting (The section of Robotic partial nephrectomy)
• Recipient of Outstanding Poster in 2014 AUA annual meeting (The section of Urothelial carcinoma of the upper urinary tract)
• Recipient of Best poster in 2010 AUA annual meeting (The section of Urothelial carcinoma of the upper urinary tract)
• Recipient of the reviewer of the year 2015: International Journal of Urology
• Recipient of the reviewer of the year 2016: International Journal of Urology,

Special interest;

Dr. Kondo is active in both laparoscopic & robotic surgery and extended surgery in kidney, upper urinary tract, and bladder cancer.  He is also active in treatment of metastatic kidney cancer with targeted or cytokine therapy as an oncologist.